Search research articles
Contact Us
Filters
Showing results (581-590 of 751) with videos related to
Page
of 76
Sort By:
American Heart Journal
|
September 3, 2011
Medication adherence: a call for action
Hayden B Bosworth, Bradi B Granger, Phil Mendys, et al.
Circulation
|
November 20, 2014
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction
Søren L Kristensen, Lars Køber, Pardeep S Jhund, et al.
Mayo Clinic Proceedings. Digital Health
|
July 17, 2025
Racial and Ethnic Representation and Study Engagement in a Siteless Digital Clinical Trial Using a Smartwatch: Findings From the Apple Heart Study
Kaylin T Nguyen, Jingzhi Yu, Haley Hedlin, et al.
Resuscitation
|
June 28, 2014
Diurnal variations in incidence and outcome of out-of-hospital cardiac arrest including prior comorbidity and pharmacotherapy: a nationwide study in Denmark
Lena I M Karlsson, Mads Wissenberg, Emil L Fosbøl, et al.
European Journal of Heart Failure
|
December 18, 2024
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trials
Alberto Foà, Maria A Pabon, Eugene Braunwald, et al.
Circulation
|
February 8, 2021
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update
Dominick J Angiolillo, Deepak L Bhatt, Christopher P Cannon, et al.
European Journal of Heart Failure
|
December 26, 2006
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM
Eldrin F Lewis, Gervasio A Lamas, Eileen O'Meara, et al.
European Heart Journal
|
February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2
Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
American Heart Journal
|
May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
Raffaele De Caterina, Ulrika Andersson, John H Alexander, et al.
JAMA
|
November 17, 2014
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction
Duk-Woo Park, Robert M Clare, Phillip J Schulte, et al.
Page
of 76
Search research articles
Search
Showing results (581-590 of 751) with videos related to
Sort By:
Page
of 76
American Heart Journal
|
September 3, 2011
Medication adherence: a call for action
Hayden B Bosworth, Bradi B Granger, Phil Mendys, et al.
Circulation
|
November 20, 2014
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction
Søren L Kristensen, Lars Køber, Pardeep S Jhund, et al.
Mayo Clinic Proceedings. Digital Health
|
July 17, 2025
Racial and Ethnic Representation and Study Engagement in a Siteless Digital Clinical Trial Using a Smartwatch: Findings From the Apple Heart Study
Kaylin T Nguyen, Jingzhi Yu, Haley Hedlin, et al.
Resuscitation
|
June 28, 2014
Diurnal variations in incidence and outcome of out-of-hospital cardiac arrest including prior comorbidity and pharmacotherapy: a nationwide study in Denmark
Lena I M Karlsson, Mads Wissenberg, Emil L Fosbøl, et al.
European Journal of Heart Failure
|
December 18, 2024
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trials
Alberto Foà, Maria A Pabon, Eugene Braunwald, et al.
Circulation
|
February 8, 2021
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update
Dominick J Angiolillo, Deepak L Bhatt, Christopher P Cannon, et al.
European Journal of Heart Failure
|
December 26, 2006
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM
Eldrin F Lewis, Gervasio A Lamas, Eileen O'Meara, et al.
European Heart Journal
|
February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2
Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
American Heart Journal
|
May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
Raffaele De Caterina, Ulrika Andersson, John H Alexander, et al.
JAMA
|
November 17, 2014
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction
Duk-Woo Park, Robert M Clare, Phillip J Schulte, et al.
Page
of 76